Old Web
English
Sign In
Acemap
>
authorDetail
>
A. S. Chappell
A. S. Chappell
Epilepsy
Anticonvulsant
Placebo
Adverse effect
Medicine
3
Papers
200
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
2014
Journal of Pharmacology and Experimental Therapeutics
Ruud Zwart
Emanuele Sher
X. Ping
Xiaoming Jin
John Sims
A. S. Chappell
Scott D. Gleason
Patric James Hahn
Kevin Matthew Gardinier
Douglas Linn Gernert
Jon Hobbs
Jodi L. Smith
S. N. Valli
Jeffrey M. Witkin
Show All
Source
Cite
Save
Citations (50)
AMPA potentiator treatment of cognitive deficits in Alzheimer disease
2007
Neurology
A. S. Chappell
C. Gonzales
J Williams
M. M. Witte
Richard C. Mohs
Reisa A. Sperling
Show All
Source
Cite
Save
Citations (65)
A crossover, add-on trial of talampanel in patients with refractory partial seizures.
2002
Neurology
A. S. Chappell
Josemir W. Sander
M. J. Brodie
David Chadwick
A. Lledó
D Zhang
J. Bjerke
G. M. Kiesler
S. Arroyo
Show All
Source
Cite
Save
Citations (85)
1